IUPAC Traditional

2-(4-{[4-(benzyloxy)-3-methoxyphenyl]methyl}-1-(propan-2-yl)piperazin-2-yl)ethan-1-ol

Compound number MolPort-005-020-073
Molecular weight 398.547
InChI key ZPHPFEOOXZSVAW-UHFFFAOYSA-N
Molecular formula C24H34N2O3
DMSO Solubility soluble
SMILES COc1cc(CN2CCN(C(C)C)C(CCO)C2)ccc1OCc1ccccc1
Best offer
$100.00
Including direct shipping

Pack size:
5 micromol
Shipping to:
United States
Lead time:
21 business days
Adjust Requirements

ChemBridge Corporation

Direct S&H to USA
45.00 USD
Catalog
Screening compound
Ships out
21 business days
Purity
85%
Last updated
this week
In warehouse
10.00 mg
Salt: FREE

Supplier Catalogue Data

Pack size
Ships out
Price
Quantity
5 micromol
January 5, 2023
55.00 USD
1 mg
January 5, 2023
45.00 USD
5 mg
January 5, 2023
65.00 USD
Simpler, smarter compound sourcing with Molport
  • Extensive vetted supplier network
  • Smart standardised systems and intelligent fulfilment
  • Experienced support and expert lab services
We supply companies including
Fraunhofer logo Domainex logo Reverie labs logo
Search and order chemical compounds instantly
View search options
Access and search our databases offline
Access databases

More Information

Compound identifiers

Compound number
MolPort-005-020-073

Names, Synonyms and 3rd Party Identifiers

Name
2-{4-[4-(benzyloxy)-3-methoxybenzyl]-1-isopropyl-2-piperazinyl}ethanol

InChI

InChI
1/C24H34N2O3/c1-19(2)26-13-12-25(17-22(26)11-14-27)16-21-9-10-23(24(15-21)28-3)29-18-20-7-5-4-6-8-20/h4-10,15,19,22,27H,11-14,16-18H2,1-3H3
InChI key
ZPHPFEOOXZSVAW-UHFFFAOYSA-N

Formula

Molecular formula
C24H34N2O3
Molecular weight
398.547

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback